19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

LS01 Future Directions Based on Experience Developing Drugs to Treat Novel Coronavirus Infections

Session Chair(s)

Kanji Hirai, RPh

• Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
• MSD, Japan

Speaker(s)

Hiroko Kawaguchi

• Associate Director, Regulatory Affairs
• MSD K.K., Japan

Hirofumi Sone

• Manager, Japan Regulatory Lead, Regulatory Affairs
• Pfizer R&D Japan, Japan

Yuji Arakawa

• Ministry of Health, Labour and Welfare (MHLW), Japan